As an oncogene, METTL3 may introduce the methyl group into the mRNA of target genes such as MYC and BCL2, promoting its translation that leads to cell differentiation and proliferation and affects apoptosis in acute myeloid leukemia and breast cancer (12, 13). This evidence concerns the gene BCL2 and acute myeloid leukemia.